相关实验视频

Updated: Jun 23, 2026

Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models

Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models

Published on: July 7, 2016

人工智能改善了协议,并减少了在霍奇金淋巴瘤中量化代谢瘤负担的时间

May Sadik¹, Sally F Barrington², Johannes Ulén³

¹Department of Molecular and Clinical Medicine, Clinical Physiology, Sahlgrenska University Hospital, Sahlgrenska Academy at the University of Gothenburg, 413 90 Gothenburg, Sweden.

Hematology reports

|November 24, 2025

概括

一个人工智能 (AI) 工具改善了专家之间的协议,用于测量霍奇金淋巴瘤 (HL) 患者的总代谢瘤体积 (tMTV),使用[18F]FDG PET/CT扫描. 这种人工智能支持提高了定量成像分析的一致性.

科学领域:

核医学是一种核医学.
在瘤学瘤学.
人工智能在医学中的应用

背景情况:

精确量化总代谢瘤体积 (tMTV) 对于使用[18F]FDG PET/CT.CT进行霍奇金淋巴瘤 (HL) 患者的分期至关重要.
手动细分的观察者之间的变化可能会影响tMTV测量的可靠性.

研究的目的:

评估基于人工智能的工具,用于在HL患者中自动化tMTV量化.
确定人工智能支持是否增强了核医学专家在损伤细分方面的观察者间协议.

主要方法:

包括48名正在接受[18F]FDG PET/CT分期的HL患者.
8名专家对12个案例进行了手动tMTV细分,对另外12个案例进行了人工智能辅助细分.
在手动和人工智能辅助细分方法之间比较了观察者间的变化.

主要成果:

手动细分之间的tMTV中位数差异为26cm3 (23%),而在人工智能辅助下,它是12cm3 (9%) (p=0.023).
在使用AI和不使用AI的测量之间,tMTV的中位数差异为3.3cm3 (2.3%).
人工智能显著增加了tMTV量化专家之间的共识.

结论:

一个自动化的人工智能工具显著改善了专家之间的协议,以量化HL患者的tMTV.
人工智能辅助的细分可以提高[18F]FDG PET/CT定量分析的一致性,而不会大幅改变测量结果.

关键词:

化氧葡萄糖F18F18 化氧葡萄糖F18 霍奇金病是一种霍奇金病.人工智能的人工智能是人工智能.观察者变化的变化.总代谢性瘤体积的总量

更多相关视频

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...